person

Chantal B. M.

Country
France
Department
Oncologie médicale

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
60
Sites with multiple studies

Has run more than one trial at 60 of 172 partner sites.

Specializations

Breast Cancer Therapeutics

The investigator specializes in treating various forms of breast cancer, with particular emphasis on hormone receptor-positive (HR+) and HER2-negative breast cancer. Their research encompasses both early-stage and metastatic disease management.

  • Advanced Endocrine Therapy Combinations
  • ESR1 Mutation Detection
  • Neoadjuvant Treatment Approaches

Their work includes innovative approaches in circulating tumor DNA analysis for treatment monitoring.

Triple-Negative Breast Cancer

The investigator focuses on advancing treatment strategies for triple-negative breast cancer (TNBC), particularly in the context of immunotherapy response and personalized treatment approaches.

  • Immunotherapy Optimization
  • Pathologic Complete Response Assessment
  • Post-Neoadjuvant Treatment Strategies

Their research explores treatment customization based on individual patient response patterns.

Prostate Cancer Management

The investigator conducts research in metastatic prostate cancer treatment, with particular attention to vulnerable patient populations and hormone therapy optimization.

  • Androgen Deprivation Therapy
  • Novel Hormone Treatment Combinations
  • Personalized Treatment for Frail Patients

Their work addresses specific needs of patients with compromised functional ability requiring targeted therapeutic approaches.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.